ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
4 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
18 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Raising awareness of ResAppDx and SleepCheck
|
|
Cosmoclarke
|
52 |
13K |
4 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Resapphealth 2022
|
|
Cosmoclarke
|
214 |
59K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
214
|
59K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
4 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
0 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
1 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate enters licence agreement with ResApp Health
|
|
Cosmoclarke
|
122 |
41K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
122
|
41K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
0 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Resapphealth 2022
|
|
Cosmoclarke
|
214 |
59K |
15 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
214
|
59K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
117 |
37K |
6 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
117
|
37K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
117 |
37K |
25 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
117
|
37K
|
25
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
Cosmoclarke
|
21 |
6.6K |
3 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
21
|
6.6K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx goes live with Doctors on Demand in Australia
|
|
Cosmoclarke
|
46 |
15K |
5 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
46
|
15K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
5 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
1.0K
|
296K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Publication highlights use of ResAppDx in COVID-19 clinic
|
|
Cosmoclarke
|
40 |
10K |
4 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
40
|
10K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Publication highlights use of ResAppDx in COVID-19 clinic
|
|
Cosmoclarke
|
40 |
10K |
6 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
40
|
10K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
1 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
1.0K
|
296K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
18 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
1.0K
|
296K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: US COVID-19 study completes recruitment
|
|
Cosmoclarke
|
20 |
5.7K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
20
|
5.7K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
1.0K
|
296K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
11 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
0 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
1 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
2 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
7 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
4 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
0 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
Cosmoclarke
|
387 |
100K |
2 |
26/12/21 |
26/12/21 |
ASX - By Stock
|
387
|
100K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
Cosmoclarke
|
387 |
100K |
7 |
26/12/21 |
26/12/21 |
ASX - By Stock
|
387
|
100K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
Cosmoclarke
|
387 |
100K |
5 |
26/12/21 |
26/12/21 |
ASX - By Stock
|
387
|
100K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
ResApp could be the future of COVID-19 screening
|
|
Cosmoclarke
|
181 |
59K |
1 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
181
|
59K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
0 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
2 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Establishes COVID-19 Scientific Advisory Board
|
|
Cosmoclarke
|
33 |
8.7K |
12 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
33
|
8.7K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
3 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
1.0K
|
296K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Cosmoclarke
|
49 |
13K |
1 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
49
|
13K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Cosmoclarke
|
49 |
13K |
11 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
49
|
13K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Cosmoclarke
|
49 |
13K |
0 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
49
|
13K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Cosmoclarke
|
49 |
13K |
3 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
49
|
13K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Cosmoclarke
|
49 |
13K |
5 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
49
|
13K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives regulatory approvals for cough counter
|
|
Cosmoclarke
|
23 |
6.9K |
7 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
23
|
6.9K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
Cosmoclarke
|
387 |
100K |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
387
|
100K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
Cosmoclarke
|
387 |
100K |
1 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
387
|
100K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Publication on challenges of diagnosing respiratory disease
|
|
Cosmoclarke
|
44 |
12K |
23 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
44
|
12K
|
23
|
|
ASX - By Stock
|
RAP |
Re:
RAP Overview
|
|
Cosmoclarke
|
33 |
10K |
20 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
33
|
10K
|
20
|
|
ASX - By Stock
|
RAP |
Re:
Ann: COVID-19 Clinical Studies Update
|
|
Cosmoclarke
|
97 |
33K |
0 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
97
|
33K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting
|
|
Cosmoclarke
|
26 |
10K |
3 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
26
|
10K
|
3
|
|